Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial
Authors
Keywords
-
Journal
PAIN MEDICINE
Volume 16, Issue 1, Pages 149-159
Publisher
Oxford University Press (OUP)
Online
2014-10-07
DOI
10.1111/pme.12569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
- (2013) Djordje Miljković et al. ANTIOXIDANTS & REDOX SIGNALING
- Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis
- (2013) F. Begum et al. Journal of Neuroimmune Pharmacology
- The Immune Pathogenesis of Multiple Sclerosis
- (2013) Robert Weissert Journal of Neuroimmune Pharmacology
- Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
- (2013) Slava Rom et al. Journal of Neuroimmune Pharmacology
- A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Gabapentin Enacarbil in Subjects With Neuropathic Pain Associated With Postherpetic Neuralgia (PXN110748)
- (2013) Lixin Zhang et al. JOURNAL OF PAIN
- Combined carbamazepine and pregabalin therapy in a rat model of neuropathic pain
- (2012) T.S. Hahm et al. BRITISH JOURNAL OF ANAESTHESIA
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Probable involvement of Ca2+-activated Cl− channels (CaCCs) in the activation of CB1 cannabinoid receptors
- (2012) Thiago Roberto Lima Romero et al. LIFE SCIENCES
- Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
- (2012) Eva de Lago et al. NEUROPHARMACOLOGY
- An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
- (2012) Cory Toth et al. PAIN
- A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
- (2012) Richard Rauck et al. Pain Practice
- Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients
- (2012) SanjayKumar Kanodia et al. INDIAN JOURNAL OF DERMATOLOGY
- The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain
- (2011) Gabi Zeilig et al. BRAIN
- Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
- (2011) Mary E. Lynch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Neuroprotective agents: Cannabinoids
- (2011) A.J. Sánchez et al. CLINICAL IMMUNOLOGY
- Role of Cannabinoids in Multiple Sclerosis
- (2011) John P. Zajicek et al. CNS DRUGS
- Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy
- (2011) V. Spallone et al. DIABETIC MEDICINE
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Preoperative Gabapentin for Acute Post-thoracotomy Analgesia: A Randomized, Double-Blinded, Active Placebo-Controlled Study
- (2011) Michelle A. O. Kinney et al. Pain Practice
- The abuse potential of the synthetic cannabinoid nabilone
- (2010) Mark A. Ware et al. ADDICTION
- Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran
- (2010) Michael E. Geisser et al. PAIN
- NeuPSIG guidelines on neuropathic pain assessment
- (2010) Maija Haanpää et al. PAIN
- An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy
- (2010) Jennifer A. Bestard et al. Pain Practice
- Treatment of Neuropathic Pain: An Overview of Recent Guidelines
- (2009) Alec B. O'Connor et al. AMERICAN JOURNAL OF MEDICINE
- Examining the roles of cannabinoids in pain and other therapeutic indications: a review
- (2009) Dana Turcotte et al. EXPERT OPINION ON PHARMACOTHERAPY
- Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
- (2009) Ian Gilron et al. LANCET
- Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia
- (2009) M. Melanson et al. Multiple Sclerosis Journal
- A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
- (2008) L. Mestre et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Nabilone for the Treatment of Pain in Fibromyalgia
- (2007) Ryan Quinlan Skrabek et al. JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now